Doing the Same with Less: A Randomized, Multinational, Open-Label, Adjudicator-Blinded Trial of an Algorithm vs. Standard of Care to Determine Treatment Duration for Staphylococcal Bacteremia

Abstract Background The appropriate duration of antibiotics for staphylococcal bloodstream infection (BSI) is unknown. An algorithm to identify patients with staphylococcal BSI who can be safely treated with shorter courses of therapy would improve care and reduce total antibiotic use. Methods Adult...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Open forum infectious diseases 2017-10, Vol.4 (suppl_1), p.S29-S29
Hauptverfasser: Holland, Thomas L, Boucher, Helen W, Raad, Issam, Anderson, Deverick J, Cosgrove, Sara E, Aycock, Suzanne, Baddley, John W, Chow, Shein-Chung, Chu, Vivian H, Cook, Paul P, Corey, G Ralph, Daly, Jennifer S, Hachem, Ray Y, Chaftari, Anne-Marie, Horton, James M, Jenkins, Timothy C, Gu, Jiezhun, Levine, Donald P, Miro, Jose M, Riska, Paul, Rubin, Zachary A, Rupp, Mark E, Schrank, John, Sims, Matthew, Wray, Dannah, Zervos, Marcus J, Fowler, Vance
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S29
container_issue suppl_1
container_start_page S29
container_title Open forum infectious diseases
container_volume 4
creator Holland, Thomas L
Boucher, Helen W
Raad, Issam
Anderson, Deverick J
Cosgrove, Sara E
Aycock, Suzanne
Baddley, John W
Chow, Shein-Chung
Chu, Vivian H
Cook, Paul P
Corey, G Ralph
Daly, Jennifer S
Hachem, Ray Y
Chaftari, Anne-Marie
Horton, James M
Jenkins, Timothy C
Gu, Jiezhun
Levine, Donald P
Miro, Jose M
Riska, Paul
Rubin, Zachary A
Rupp, Mark E
Schrank, John
Sims, Matthew
Wray, Dannah
Zervos, Marcus J
Fowler, Vance
description Abstract Background The appropriate duration of antibiotics for staphylococcal bloodstream infection (BSI) is unknown. An algorithm to identify patients with staphylococcal BSI who can be safely treated with shorter courses of therapy would improve care and reduce total antibiotic use. Methods Adult patients with staphylococcal BSI were randomized to treatment based on algorithm-based therapy (ABT) or to standard of care (SOC). Co-primary outcomes were clinical success, as determined by a blinded Adjudication Committee, and serious adverse event (SAE) rates. The prespecified secondary outcome measure was antibiotic days by treatment group, among patients without complicated BSI. Prespecified durations of therapy in ABT were: S. aureus BSI (SAB): uncomplicated: 14 days; complicated: 4–6 weeks. Coagulase-negative staphylococci BSI (CoNSB): simple (1 positive blood culture) (0–3 days), uncomplicated (>1 positive blood culture) (5 days), complicated (7–28 days). Outcomes were compared using intention-to-treat principles. The target sample size was 500 patients, to ensure 90% power for establishing noninferiority within a margin of 15%. Results Between April 2011 and March 2017, 509 adults with suspected staphylococcal BSI at 16 sites in the US and Spain were randomized to ABT (N = 255) or SOC (N = 254). There were 116 patients with SAB (23%) and 385 (76%) with CoNSB (Figure 1). Overall success rate in the ABT group was 82.0% vs. 81.5% in the SOC group, difference 0.5%, 95% CI −5.2% to 6.1%. SAEs were reported in 32.9% of ABT vs. 28.3% of SOC patients (OR 1.2, 95% CI 0.9 to 1.8). Among evaluable patients without complicated BSI, mean duration of therapy was 4.4 days in the ABT group vs. 6.4 days in the SOC group (difference −2.0 days, 95% CI −3.3 to −-0.7, P = 0.003). Among patients with uncomplicated SAB, treatment durations were similar (15.3 days in ABT vs. 16.3 days in SOC, difference −1 day, 95% CI −3.89 to 1.91, P = 0.497), whereas for uncomplicated CoNSB, duration was shorter in the ABT group (5.3 days in ABT vs. 8.4 days in SOC, difference −3 days, 95% CI −4.87 to −1.34, P 
doi_str_mv 10.1093/ofid/ofx162.072
format Article
fullrecord <record><control><sourceid>oup_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5632232</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ofid/ofx162.072</oup_id><sourcerecordid>10.1093/ofid/ofx162.072</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1712-5a8b6405e84b3054b7d047f0afe09f8ecb0fcbdeca80a52aa2a8f386881f85123</originalsourceid><addsrcrecordid>eNqFkc9uEzEQh1cIJKrSM9c5o25qe7NZhwNSmpQ_UlAlWs7WrD1OXO3aK6-30D4Nj4J4MhyCEJy42CPNfN-M9CuKl5zNOFtWF8E6k5-vfCFmrBFPihNRCVnKZd08_at-XpyN4x1jjHNWs2Z5UnzfBOd3kPYEN9gTfHFpD1sax9ew-vHtE3oTevdI5hw-Tl1yHpMLHrtzuB7Il1tsKdcrczcZpzGFWF52zhsycBsddhAsoIdVtwsxi3u4H2dwk7IVozk01xgJUoANJYq985Q5wtSTT7CZ4q9tYEM8QMP-oQs6aJ29l6gzQL3DF8Uzi91IZ7__0-Lz26vb9ftye_3uw3q1LTVvuChrlO1izmqS87Zi9bxtDJs3lqEltrSSdMusbg1plAxrgShQ2koupORW1lxUp8Wbo3eY2p6MzhdG7NQQXY_xQQV06t-Od3u1C_eqXlQiB5AFF0eBjmEcI9k_LGfqEKI6hKiOIaocYiZeHYkwDf8d_gmIW6UK</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Doing the Same with Less: A Randomized, Multinational, Open-Label, Adjudicator-Blinded Trial of an Algorithm vs. Standard of Care to Determine Treatment Duration for Staphylococcal Bacteremia</title><source>Oxford Journals Open Access Collection</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Holland, Thomas L ; Boucher, Helen W ; Raad, Issam ; Anderson, Deverick J ; Cosgrove, Sara E ; Aycock, Suzanne ; Baddley, John W ; Chow, Shein-Chung ; Chu, Vivian H ; Cook, Paul P ; Corey, G Ralph ; Daly, Jennifer S ; Hachem, Ray Y ; Chaftari, Anne-Marie ; Horton, James M ; Jenkins, Timothy C ; Gu, Jiezhun ; Levine, Donald P ; Miro, Jose M ; Riska, Paul ; Rubin, Zachary A ; Rupp, Mark E ; Schrank, John ; Sims, Matthew ; Wray, Dannah ; Zervos, Marcus J ; Fowler, Vance</creator><creatorcontrib>Holland, Thomas L ; Boucher, Helen W ; Raad, Issam ; Anderson, Deverick J ; Cosgrove, Sara E ; Aycock, Suzanne ; Baddley, John W ; Chow, Shein-Chung ; Chu, Vivian H ; Cook, Paul P ; Corey, G Ralph ; Daly, Jennifer S ; Hachem, Ray Y ; Chaftari, Anne-Marie ; Horton, James M ; Jenkins, Timothy C ; Gu, Jiezhun ; Levine, Donald P ; Miro, Jose M ; Riska, Paul ; Rubin, Zachary A ; Rupp, Mark E ; Schrank, John ; Sims, Matthew ; Wray, Dannah ; Zervos, Marcus J ; Fowler, Vance</creatorcontrib><description>Abstract Background The appropriate duration of antibiotics for staphylococcal bloodstream infection (BSI) is unknown. An algorithm to identify patients with staphylococcal BSI who can be safely treated with shorter courses of therapy would improve care and reduce total antibiotic use. Methods Adult patients with staphylococcal BSI were randomized to treatment based on algorithm-based therapy (ABT) or to standard of care (SOC). Co-primary outcomes were clinical success, as determined by a blinded Adjudication Committee, and serious adverse event (SAE) rates. The prespecified secondary outcome measure was antibiotic days by treatment group, among patients without complicated BSI. Prespecified durations of therapy in ABT were: S. aureus BSI (SAB): uncomplicated: 14 days; complicated: 4–6 weeks. Coagulase-negative staphylococci BSI (CoNSB): simple (1 positive blood culture) (0–3 days), uncomplicated (&gt;1 positive blood culture) (5 days), complicated (7–28 days). Outcomes were compared using intention-to-treat principles. The target sample size was 500 patients, to ensure 90% power for establishing noninferiority within a margin of 15%. Results Between April 2011 and March 2017, 509 adults with suspected staphylococcal BSI at 16 sites in the US and Spain were randomized to ABT (N = 255) or SOC (N = 254). There were 116 patients with SAB (23%) and 385 (76%) with CoNSB (Figure 1). Overall success rate in the ABT group was 82.0% vs. 81.5% in the SOC group, difference 0.5%, 95% CI −5.2% to 6.1%. SAEs were reported in 32.9% of ABT vs. 28.3% of SOC patients (OR 1.2, 95% CI 0.9 to 1.8). Among evaluable patients without complicated BSI, mean duration of therapy was 4.4 days in the ABT group vs. 6.4 days in the SOC group (difference −2.0 days, 95% CI −3.3 to −-0.7, P = 0.003). Among patients with uncomplicated SAB, treatment durations were similar (15.3 days in ABT vs. 16.3 days in SOC, difference −1 day, 95% CI −3.89 to 1.91, P = 0.497), whereas for uncomplicated CoNSB, duration was shorter in the ABT group (5.3 days in ABT vs. 8.4 days in SOC, difference −3 days, 95% CI −4.87 to −1.34, P &lt; 0.001). Conclusion The use of a treatment algorithm for staphylococcal BSI was associated with significant reductions in duration of antibiotic therapy in patients without complicated BSI, without significant differences in overall success or SAEs. Figure 1. Schematic of Study Design Disclosures V. Fowler Jr., NIH: Investigator, Contract HHSN272200900023C</description><identifier>ISSN: 2328-8957</identifier><identifier>EISSN: 2328-8957</identifier><identifier>DOI: 10.1093/ofid/ofx162.072</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Abstracts</subject><ispartof>Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S29-S29</ispartof><rights>The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632232/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632232/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1598,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Holland, Thomas L</creatorcontrib><creatorcontrib>Boucher, Helen W</creatorcontrib><creatorcontrib>Raad, Issam</creatorcontrib><creatorcontrib>Anderson, Deverick J</creatorcontrib><creatorcontrib>Cosgrove, Sara E</creatorcontrib><creatorcontrib>Aycock, Suzanne</creatorcontrib><creatorcontrib>Baddley, John W</creatorcontrib><creatorcontrib>Chow, Shein-Chung</creatorcontrib><creatorcontrib>Chu, Vivian H</creatorcontrib><creatorcontrib>Cook, Paul P</creatorcontrib><creatorcontrib>Corey, G Ralph</creatorcontrib><creatorcontrib>Daly, Jennifer S</creatorcontrib><creatorcontrib>Hachem, Ray Y</creatorcontrib><creatorcontrib>Chaftari, Anne-Marie</creatorcontrib><creatorcontrib>Horton, James M</creatorcontrib><creatorcontrib>Jenkins, Timothy C</creatorcontrib><creatorcontrib>Gu, Jiezhun</creatorcontrib><creatorcontrib>Levine, Donald P</creatorcontrib><creatorcontrib>Miro, Jose M</creatorcontrib><creatorcontrib>Riska, Paul</creatorcontrib><creatorcontrib>Rubin, Zachary A</creatorcontrib><creatorcontrib>Rupp, Mark E</creatorcontrib><creatorcontrib>Schrank, John</creatorcontrib><creatorcontrib>Sims, Matthew</creatorcontrib><creatorcontrib>Wray, Dannah</creatorcontrib><creatorcontrib>Zervos, Marcus J</creatorcontrib><creatorcontrib>Fowler, Vance</creatorcontrib><title>Doing the Same with Less: A Randomized, Multinational, Open-Label, Adjudicator-Blinded Trial of an Algorithm vs. Standard of Care to Determine Treatment Duration for Staphylococcal Bacteremia</title><title>Open forum infectious diseases</title><description>Abstract Background The appropriate duration of antibiotics for staphylococcal bloodstream infection (BSI) is unknown. An algorithm to identify patients with staphylococcal BSI who can be safely treated with shorter courses of therapy would improve care and reduce total antibiotic use. Methods Adult patients with staphylococcal BSI were randomized to treatment based on algorithm-based therapy (ABT) or to standard of care (SOC). Co-primary outcomes were clinical success, as determined by a blinded Adjudication Committee, and serious adverse event (SAE) rates. The prespecified secondary outcome measure was antibiotic days by treatment group, among patients without complicated BSI. Prespecified durations of therapy in ABT were: S. aureus BSI (SAB): uncomplicated: 14 days; complicated: 4–6 weeks. Coagulase-negative staphylococci BSI (CoNSB): simple (1 positive blood culture) (0–3 days), uncomplicated (&gt;1 positive blood culture) (5 days), complicated (7–28 days). Outcomes were compared using intention-to-treat principles. The target sample size was 500 patients, to ensure 90% power for establishing noninferiority within a margin of 15%. Results Between April 2011 and March 2017, 509 adults with suspected staphylococcal BSI at 16 sites in the US and Spain were randomized to ABT (N = 255) or SOC (N = 254). There were 116 patients with SAB (23%) and 385 (76%) with CoNSB (Figure 1). Overall success rate in the ABT group was 82.0% vs. 81.5% in the SOC group, difference 0.5%, 95% CI −5.2% to 6.1%. SAEs were reported in 32.9% of ABT vs. 28.3% of SOC patients (OR 1.2, 95% CI 0.9 to 1.8). Among evaluable patients without complicated BSI, mean duration of therapy was 4.4 days in the ABT group vs. 6.4 days in the SOC group (difference −2.0 days, 95% CI −3.3 to −-0.7, P = 0.003). Among patients with uncomplicated SAB, treatment durations were similar (15.3 days in ABT vs. 16.3 days in SOC, difference −1 day, 95% CI −3.89 to 1.91, P = 0.497), whereas for uncomplicated CoNSB, duration was shorter in the ABT group (5.3 days in ABT vs. 8.4 days in SOC, difference −3 days, 95% CI −4.87 to −1.34, P &lt; 0.001). Conclusion The use of a treatment algorithm for staphylococcal BSI was associated with significant reductions in duration of antibiotic therapy in patients without complicated BSI, without significant differences in overall success or SAEs. Figure 1. Schematic of Study Design Disclosures V. Fowler Jr., NIH: Investigator, Contract HHSN272200900023C</description><subject>Abstracts</subject><issn>2328-8957</issn><issn>2328-8957</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><recordid>eNqFkc9uEzEQh1cIJKrSM9c5o25qe7NZhwNSmpQ_UlAlWs7WrD1OXO3aK6-30D4Nj4J4MhyCEJy42CPNfN-M9CuKl5zNOFtWF8E6k5-vfCFmrBFPihNRCVnKZd08_at-XpyN4x1jjHNWs2Z5UnzfBOd3kPYEN9gTfHFpD1sax9ew-vHtE3oTevdI5hw-Tl1yHpMLHrtzuB7Il1tsKdcrczcZpzGFWF52zhsycBsddhAsoIdVtwsxi3u4H2dwk7IVozk01xgJUoANJYq985Q5wtSTT7CZ4q9tYEM8QMP-oQs6aJ29l6gzQL3DF8Uzi91IZ7__0-Lz26vb9ftye_3uw3q1LTVvuChrlO1izmqS87Zi9bxtDJs3lqEltrSSdMusbg1plAxrgShQ2koupORW1lxUp8Wbo3eY2p6MzhdG7NQQXY_xQQV06t-Od3u1C_eqXlQiB5AFF0eBjmEcI9k_LGfqEKI6hKiOIaocYiZeHYkwDf8d_gmIW6UK</recordid><startdate>20171004</startdate><enddate>20171004</enddate><creator>Holland, Thomas L</creator><creator>Boucher, Helen W</creator><creator>Raad, Issam</creator><creator>Anderson, Deverick J</creator><creator>Cosgrove, Sara E</creator><creator>Aycock, Suzanne</creator><creator>Baddley, John W</creator><creator>Chow, Shein-Chung</creator><creator>Chu, Vivian H</creator><creator>Cook, Paul P</creator><creator>Corey, G Ralph</creator><creator>Daly, Jennifer S</creator><creator>Hachem, Ray Y</creator><creator>Chaftari, Anne-Marie</creator><creator>Horton, James M</creator><creator>Jenkins, Timothy C</creator><creator>Gu, Jiezhun</creator><creator>Levine, Donald P</creator><creator>Miro, Jose M</creator><creator>Riska, Paul</creator><creator>Rubin, Zachary A</creator><creator>Rupp, Mark E</creator><creator>Schrank, John</creator><creator>Sims, Matthew</creator><creator>Wray, Dannah</creator><creator>Zervos, Marcus J</creator><creator>Fowler, Vance</creator><general>Oxford University Press</general><scope>TOX</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20171004</creationdate><title>Doing the Same with Less: A Randomized, Multinational, Open-Label, Adjudicator-Blinded Trial of an Algorithm vs. Standard of Care to Determine Treatment Duration for Staphylococcal Bacteremia</title><author>Holland, Thomas L ; Boucher, Helen W ; Raad, Issam ; Anderson, Deverick J ; Cosgrove, Sara E ; Aycock, Suzanne ; Baddley, John W ; Chow, Shein-Chung ; Chu, Vivian H ; Cook, Paul P ; Corey, G Ralph ; Daly, Jennifer S ; Hachem, Ray Y ; Chaftari, Anne-Marie ; Horton, James M ; Jenkins, Timothy C ; Gu, Jiezhun ; Levine, Donald P ; Miro, Jose M ; Riska, Paul ; Rubin, Zachary A ; Rupp, Mark E ; Schrank, John ; Sims, Matthew ; Wray, Dannah ; Zervos, Marcus J ; Fowler, Vance</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1712-5a8b6405e84b3054b7d047f0afe09f8ecb0fcbdeca80a52aa2a8f386881f85123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Abstracts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Holland, Thomas L</creatorcontrib><creatorcontrib>Boucher, Helen W</creatorcontrib><creatorcontrib>Raad, Issam</creatorcontrib><creatorcontrib>Anderson, Deverick J</creatorcontrib><creatorcontrib>Cosgrove, Sara E</creatorcontrib><creatorcontrib>Aycock, Suzanne</creatorcontrib><creatorcontrib>Baddley, John W</creatorcontrib><creatorcontrib>Chow, Shein-Chung</creatorcontrib><creatorcontrib>Chu, Vivian H</creatorcontrib><creatorcontrib>Cook, Paul P</creatorcontrib><creatorcontrib>Corey, G Ralph</creatorcontrib><creatorcontrib>Daly, Jennifer S</creatorcontrib><creatorcontrib>Hachem, Ray Y</creatorcontrib><creatorcontrib>Chaftari, Anne-Marie</creatorcontrib><creatorcontrib>Horton, James M</creatorcontrib><creatorcontrib>Jenkins, Timothy C</creatorcontrib><creatorcontrib>Gu, Jiezhun</creatorcontrib><creatorcontrib>Levine, Donald P</creatorcontrib><creatorcontrib>Miro, Jose M</creatorcontrib><creatorcontrib>Riska, Paul</creatorcontrib><creatorcontrib>Rubin, Zachary A</creatorcontrib><creatorcontrib>Rupp, Mark E</creatorcontrib><creatorcontrib>Schrank, John</creatorcontrib><creatorcontrib>Sims, Matthew</creatorcontrib><creatorcontrib>Wray, Dannah</creatorcontrib><creatorcontrib>Zervos, Marcus J</creatorcontrib><creatorcontrib>Fowler, Vance</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Open forum infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Holland, Thomas L</au><au>Boucher, Helen W</au><au>Raad, Issam</au><au>Anderson, Deverick J</au><au>Cosgrove, Sara E</au><au>Aycock, Suzanne</au><au>Baddley, John W</au><au>Chow, Shein-Chung</au><au>Chu, Vivian H</au><au>Cook, Paul P</au><au>Corey, G Ralph</au><au>Daly, Jennifer S</au><au>Hachem, Ray Y</au><au>Chaftari, Anne-Marie</au><au>Horton, James M</au><au>Jenkins, Timothy C</au><au>Gu, Jiezhun</au><au>Levine, Donald P</au><au>Miro, Jose M</au><au>Riska, Paul</au><au>Rubin, Zachary A</au><au>Rupp, Mark E</au><au>Schrank, John</au><au>Sims, Matthew</au><au>Wray, Dannah</au><au>Zervos, Marcus J</au><au>Fowler, Vance</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Doing the Same with Less: A Randomized, Multinational, Open-Label, Adjudicator-Blinded Trial of an Algorithm vs. Standard of Care to Determine Treatment Duration for Staphylococcal Bacteremia</atitle><jtitle>Open forum infectious diseases</jtitle><date>2017-10-04</date><risdate>2017</risdate><volume>4</volume><issue>suppl_1</issue><spage>S29</spage><epage>S29</epage><pages>S29-S29</pages><issn>2328-8957</issn><eissn>2328-8957</eissn><abstract>Abstract Background The appropriate duration of antibiotics for staphylococcal bloodstream infection (BSI) is unknown. An algorithm to identify patients with staphylococcal BSI who can be safely treated with shorter courses of therapy would improve care and reduce total antibiotic use. Methods Adult patients with staphylococcal BSI were randomized to treatment based on algorithm-based therapy (ABT) or to standard of care (SOC). Co-primary outcomes were clinical success, as determined by a blinded Adjudication Committee, and serious adverse event (SAE) rates. The prespecified secondary outcome measure was antibiotic days by treatment group, among patients without complicated BSI. Prespecified durations of therapy in ABT were: S. aureus BSI (SAB): uncomplicated: 14 days; complicated: 4–6 weeks. Coagulase-negative staphylococci BSI (CoNSB): simple (1 positive blood culture) (0–3 days), uncomplicated (&gt;1 positive blood culture) (5 days), complicated (7–28 days). Outcomes were compared using intention-to-treat principles. The target sample size was 500 patients, to ensure 90% power for establishing noninferiority within a margin of 15%. Results Between April 2011 and March 2017, 509 adults with suspected staphylococcal BSI at 16 sites in the US and Spain were randomized to ABT (N = 255) or SOC (N = 254). There were 116 patients with SAB (23%) and 385 (76%) with CoNSB (Figure 1). Overall success rate in the ABT group was 82.0% vs. 81.5% in the SOC group, difference 0.5%, 95% CI −5.2% to 6.1%. SAEs were reported in 32.9% of ABT vs. 28.3% of SOC patients (OR 1.2, 95% CI 0.9 to 1.8). Among evaluable patients without complicated BSI, mean duration of therapy was 4.4 days in the ABT group vs. 6.4 days in the SOC group (difference −2.0 days, 95% CI −3.3 to −-0.7, P = 0.003). Among patients with uncomplicated SAB, treatment durations were similar (15.3 days in ABT vs. 16.3 days in SOC, difference −1 day, 95% CI −3.89 to 1.91, P = 0.497), whereas for uncomplicated CoNSB, duration was shorter in the ABT group (5.3 days in ABT vs. 8.4 days in SOC, difference −3 days, 95% CI −4.87 to −1.34, P &lt; 0.001). Conclusion The use of a treatment algorithm for staphylococcal BSI was associated with significant reductions in duration of antibiotic therapy in patients without complicated BSI, without significant differences in overall success or SAEs. Figure 1. Schematic of Study Design Disclosures V. Fowler Jr., NIH: Investigator, Contract HHSN272200900023C</abstract><cop>US</cop><pub>Oxford University Press</pub><doi>10.1093/ofid/ofx162.072</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2328-8957
ispartof Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S29-S29
issn 2328-8957
2328-8957
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5632232
source Oxford Journals Open Access Collection; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Abstracts
title Doing the Same with Less: A Randomized, Multinational, Open-Label, Adjudicator-Blinded Trial of an Algorithm vs. Standard of Care to Determine Treatment Duration for Staphylococcal Bacteremia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T17%3A33%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Doing%20the%20Same%20with%20Less:%20A%C2%A0Randomized,%20Multinational,%20Open-Label,%20Adjudicator-Blinded%20Trial%20of%20an%20Algorithm%20vs.%20Standard%20of%20Care%20to%20Determine%20Treatment%20Duration%20for%20Staphylococcal%20Bacteremia&rft.jtitle=Open%20forum%20infectious%20diseases&rft.au=Holland,%20Thomas%20L&rft.date=2017-10-04&rft.volume=4&rft.issue=suppl_1&rft.spage=S29&rft.epage=S29&rft.pages=S29-S29&rft.issn=2328-8957&rft.eissn=2328-8957&rft_id=info:doi/10.1093/ofid/ofx162.072&rft_dat=%3Coup_pubme%3E10.1093/ofid/ofx162.072%3C/oup_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/ofid/ofx162.072&rfr_iscdi=true